1 Huanli X, "Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis" 5 : 202-210, 2011
2 Kadoma Y, "Radical-scavenging activity of natural methoxyphenols vs. synthetic ones using the induction period method" 12 : 130-138, 2007
3 Lin Y-R, "Neuroprotective activity of honokiol and magnolol in (erebellar granule cell damage" 537 : 64-69, 2006
4 Wen J, "Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model" 124 : 2709-2718, 2009
5 Sharma BK, "Industrial chemistry" Krishna Prakashan 1991
6 Böhmdorfer M, "In vitro metabolism and disposition of honokiol in rat and human livers" 100 : 3506-3516, 2011
7 Wang X-H, "Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol" 410 : 169-174, 2011
8 Lin J-W, "Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic bax-mitochondrioncytochrome c-caspase protease pathway" 14 : 302-314, 2012
9 Dikalov S, "Honokiol is a potent scavenger of superoxide and peroxyl radicals" 76 : 589-596, 2008
10 Tse AK-W, "Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation" 70 : 1443-1457, 2005
1 Huanli X, "Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis" 5 : 202-210, 2011
2 Kadoma Y, "Radical-scavenging activity of natural methoxyphenols vs. synthetic ones using the induction period method" 12 : 130-138, 2007
3 Lin Y-R, "Neuroprotective activity of honokiol and magnolol in (erebellar granule cell damage" 537 : 64-69, 2006
4 Wen J, "Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model" 124 : 2709-2718, 2009
5 Sharma BK, "Industrial chemistry" Krishna Prakashan 1991
6 Böhmdorfer M, "In vitro metabolism and disposition of honokiol in rat and human livers" 100 : 3506-3516, 2011
7 Wang X-H, "Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol" 410 : 169-174, 2011
8 Lin J-W, "Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic bax-mitochondrioncytochrome c-caspase protease pathway" 14 : 302-314, 2012
9 Dikalov S, "Honokiol is a potent scavenger of superoxide and peroxyl radicals" 76 : 589-596, 2008
10 Tse AK-W, "Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation" 70 : 1443-1457, 2005
11 Valko M, "Free radicals and antioxidants in normal physiological functions and human disease" 39 : 44-84, 2007
12 Zhao C, "Comparison of antioxidant abilities of magnolol and honokiol to scavenge radicals and to protect DNA" 93 : 1755-1760, 2011
13 Grenier J-L, "Antioxidant properties of nitrocaffeic acids" 6 : 431-434, 1996
14 Gülçin. I, "Antioxidant activity of food constituents : an overview" 86 : 345-391, 2012
15 Erkan N, "Antioxidant activities of rosemary (Rosmarinus officinalis L.) extract, blackseed (Nigella sativa L.) essential oil, carnosic acid, rosmarinic acid and sesamol" 110 : 76-82, 2008
16 Lee J, "Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-κB activation signaling" 71 : 338-343, 2005